As the economy takes a downturn in the second quarter of 2022, and gloomy projections of the market have translated into investors becoming more conservative in their movements, early stage seed startups in healthcare have been slowly beginning to feel the effects. Whereas the digital health, biotech, and life sciences industries have long required more due diligence in respect to their technology and more scrutiny in consideration of the consequences of their failures to their clients, investors in healthcare, much like their counterparts in other fields have reduced their risk appetite even further. In the first quarter, VC funding in…...
Are we getting distracted by AI? Data-based Care
1 min read